Table 2. Access to high blood pressure medication by hypertension patients with medical indication for drug treatment by age, gender, ABEP and Brazilian region. PNAUM, Brazil, 2104a.

Variable		Full accessb		Partial accessc		No accessd		p
		%	95CI%	%	95CI%	%	95CI%
Gender	Male	98.6	97.8–99.0	1.3	0.9–2.0	0.1	0.0–0.3
	Female	97.6	96.8–98.2	2.2	1.6–3.0	0.3	0.1–0.5	0.046
Age group	20 to 59	97.2	96.1–97.9	2.5	1.7–3.5	0.4	0.2–0.7
	60 or over	98.6	98.0–99.1	1.3	0.9–1.9	0.05	0.0–0.1	0.001
Brazilian region	North	97.1	93.6–98.7	2.5	1.0–6.2	0.3	0.2–0.7
	Northeast	96.1	94.4–97.2	3.3	2.2–4.9	0.6	0.3–1.4
	Southeast	98.7	97.7–99.2	1.3	0.7–2.2	0.1	0.0–0.4
	South	99.2	98.3–99.6	0.7	0.3–1.6	0.1	0.0–0.5
	Midwest	95.7	93.8–97.0	4.0	2.7–5.8	0.4	0.1–1.1	< 0.001
CCEBe	A/B	98.6	97.6–99.2	1.0	0.5–2.0	0.4	0.1–1.2
	C	97.7	96.8–98.3	2.2	1.6–3.0	0.1	0.1–0.3
	D/E	97.7	96.6–98.5	2.0	1.3–3.2	0.3	0.1–0.6	0.103
Total		97.9	97.3–98.4	1.9	1.4–2.4	0.2	0.1–0.4

^a Percentage adjusted by sample weights and post-stratification according to age and gender.

^b Full access: provision of all necessary medicines to treat hypertension in the previous 30 days, either free of charge or paid for by patients.

^c Lack of any medicine to treat hypertension in the previous 30 days due to financial difficulties or unavailability at SUS (Brazilian Unified Health System).

^d No access due to financial difficulties or unavailability at SUS.

^e Classified according to Critério de Classificação Econômica Brasil 2013 (CCEB 2013 – Brazilian Economic Classification Criterion) of Associação Brasileira de Empresas de Pesquisa (ABEP – Brazilian Association of Survey Companies). Available from: http://www.abep.org